SELLAS Life Sciences (SLS) Long-Term Debt Repayments (2014 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Long-Term Debt Repayments data on file, last reported at $76000.0 in Q4 2018.

• On a quarterly basis, Long-Term Debt Repayments fell 36.67% year-over-year to $76000.0 in Q4 2018; TTM through Sep 2019 was $76000.0, a 99.01% decrease from a year earlier, with the FY2018 full-year figure at $7.6 million, up 1506.98% from the prior year.
• Long-Term Debt Repayments for Q4 2018 stood at $76000.0, down from $6.9 million in the prior quarter.
• Over the last five years, Long-Term Debt Repayments for SLS reached as high as $6.9 million in Q3 2018 and fell as low as $1000.0 in Q3 2017.
• Historically, Long-Term Debt Repayments has averaged $1.1 million across 5 years, with a median of $858000.0 in 2014.
• Across the five-year window, Long-Term Debt Repayments sank 90.61% in 2017 and jumped 693500.0% in 2018, its largest moves.
• Year by year, Long-Term Debt Repayments stood at $858000.0 in 2014, then gained by 17.6% to $1.0 million in 2015, then retreated by 20.71% to $800000.0 in 2016, then plunged by 85.0% to $120000.0 in 2017, then sank by 36.67% to $76000.0 in 2018.
• Per Business Quant data, the three most recent Long-Term Debt Repayments figures were $76000.0 in Q4 2018, $6.9 million in Q3 2018, and $589000.0 in Q1 2018.